Article info
PDFReview
A review of the use of mexiletine in patients with myotonic dystrophy and non-dystrophic myotonia
- Correspondence to Simon D'Mello, Pharmacy Department, St George's University Hospitals NHS Foundation Trust, Lanesborough Wing, Blackshaw Road, Tooting, London SW17 0QT, UK; simon892{at}hotmail.co.uk
Citation
A review of the use of mexiletine in patients with myotonic dystrophy and non-dystrophic myotonia
Publication history
- Received March 30, 2016
- Revised May 18, 2016
- Accepted May 24, 2016
- First published June 14, 2016.
Online issue publication
October 27, 2016
Article Versions
- Previous version (14 June 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/